ACOT11 Inhibitors

Chemical inhibitors of ACOT1 include a range of compounds that exert inhibitory effects through various mechanisms. Trifluoperazine, W-7 Hydrochloride, Ophiobolin A, Chlorpromazine, Thioridazine, and R24571 are all calmodulin antagonists that inhibit ACOT1 by blocking the calcium/calmodulin-dependent pathways required for its optimal enzymatic activity. These inhibitors work by impeding the interaction between calmodulin and ACOT1, which is essential for the regulation of ACOT1's function in lipid metabolism. By disrupting this interaction, these chemicals effectively reduce the activity of ACOT1, leading to decreased fatty acid hydrolysis.

Additionally, chemicals such as Phenoxybenzamine and Methylene Blue inhibit ACOT1 indirectly. Phenoxybenzamine does so by antagonizing adrenergic receptors, leading to alterations in lipid metabolism that result in reduced ACOT1 activity. Methylene Blue, on the other hand, influences the redox state of cells, which can alter the cofactor availability or oxidation state required for ACOT1's function. Genistein and Bisindolylmaleimide I inhibit ACOT1 by targeting phosphorylation events. Genistein, as a tyrosine kinase inhibitor, disrupts phosphorylation-dependent regulatory mechanisms of ACOT1, while Bisindolylmaleimide I, a protein kinase C inhibitor, alters the phosphorylation status of proteins that regulate ACOT1's role in lipid metabolism. Quercetin, another kinase inhibitor, interferes with kinase-mediated signaling pathways that are crucial for ACOT1's enzymatic activity. Lastly, LY294002 inhibits ACOT1 by disrupting insulin signaling-dependent lipid metabolism pathways, impacting the role of ACOT1 in fatty acid hydrolysis. Each of these chemicals, through their respective mechanisms, achieves the inhibition of ACOT1 by altering the biochemical and cellular pathways that govern its activity.